Tratamiento de la acalasia con toxina botulínica

Revista Espanola de Enfermedades Digestivas

Volumn 89, Issue 5, 1997, Pages 367-370

  Lopez P ^a   Castiella, A ^a   Montalvo, I ^a   Bujanda, L ^a   Alzate, L F ^a   Gil, I ^a   Arenas, J I ^a  

^a Hospital Nuestra Senora de Aranzazu   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0039133912     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Barkin JS, Guelrud M, Reiner DK, et al. Forceful balloons dilatation: An outpatient procedure for achalasia. Gastrointest Endosc 1990;36:123-6.
2. Kadakia SC, Wong RKM. Graded pneumatic dilatation using Rigiflex achalasia dilator in patients with primary esophageal achalasia. Am J Gastroenterol 1993;88:34-8.
3. Parkman HP, Reynolds JC, Ouyang A, et al. Pneumatic dilatation or esophagomyotomy. Treatment of idiopathic achalasia: Clinical outcomes and cost analysis. Dig Dis Sci 1993;38:75-85.
4. Csendes A, Braghetto I, Henríquez A, et al. Late results of prospective randomized study comparing forceful dilatation and esophagomyotomy in patients with achalasia. Gut 1989;30:299-304.
5. Traube M. On drugs and dilators for achalasia. Dig Dis Sci 1991;36:257-9.
6. Richter JE. Motility disorders of the esophagus: Achalasia Yamada T, Alpers DH, Owyang C, et al (eds). Texbook of gastroenterology. Philadelphia: Lippincott. 1991:1090-104.
7. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B. Kalloo AN. Treatment of achalasia with intrasphincteric injection of botulinum toxin: a pilot trial. Ann Intern Med 1994;121:590-1.
8. Eckard VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia trasted with pneumatic dilation. Gastroenterology 1992;103:1732-8.
9. Van Ermengen E. Ueber einem neuen anaeroben Bacillusund seine Beziehungen zum Botulismus. [Z Hyg Infektionskrankh 1897;26:1-56]. Enghlish translation Rev Infect Dis 1979;1:701-19.
10. Simpson LL. The origen, structure and pharmacologic activity of botulinum toxin. Pharmacol Rev 1981;33:155-88.
11. Das Gupta BR. The structure of botulinum neurotoxin. In Simpson LL (ed). Botulinum neurotoxin and tetanus toxin S. Diego. Calif. Academic Press 1989:53-66.
12. Melling J, Hambleton P, Shone CC. Clostridium botuliman toxins: nature and preparation for clinical use. Eye 1988;2:16-23.
13. Simpson LL. Peripheral actions of the botulinum toxins. In Simpson LL (ed). Botulinum neurotoxin and tetanus toxin. S. Diego. Calif. Academic Press 1989:153-78.
14. Avila OL, Drachman DB, Pestronk A. Neurotransmission regulates stability of acetylcholine receptors at the neuromuscular junction. J Neurosci 1989;9:2902-6.
15. Pasricha PJ, Ravich WJ, Kalloo AN. Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets. Gastroenterology 1993;105:1045-9.
16. Pasricha PJ, Racich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Intrasphincteric injection Botulinum toxin for the treatment of Achalasia. N Engl J Med 1995;332:774-8.
17. Fiorini A, Corti RE, Valero JL, Bai JC, Boerr L. Botulinum toxin is effective in the short term treatment for achalasia. Preliminary results of a randomized study [Abstract]. Gastrointest Endosc 1995;41:A27.
18. Bansal R, Scheiman JM, Barnett GH. Intrasphincteric injection of Botulinum toxin for Achalasia [abstract]. Gastrointest Endosc 1995;41:A:5.
19. Ferrari AP Jr, Siqueira ES, Brant CQ. Treatment of Achalasia in Chagas' disease with Botulinum toxin. N Engl J Med 1995;332:824-5.
20. Hambleton P, Cohen HE, Palmer BJ, Melling J. Antitoxins and Botulinum toxin treatment. Br Med J 1992;304:950-60.